Rensselaer Polytechnic Institute
Rensselaer Polytechnic Institute
About RPI Academics Research Student Life Admissions News Tour
Rensselaer Polytechnic Institute
Office for Research
Faculty INterest Inventory
Research Centers
Research Constellations
Student Research

Research Compliance

Responsible Conduct of Research

Links for Researchers

Core Facilities

Funding Opportunities

Grant Assistance

Conflict of Interest Policy

Conflict of Interest
Disclosure Form

Health & Safety

Research Related Policies


Office of Technology Commercialization

Technology Park

Administration & Finance

Export Control

Biotechnology and the Life Sciences Energy, Environment, and Smart Systems

Institutional Stem Cell Research Oversight (ISCRO)

The mission of the ISCRO is to review research involving human embryonic stem cells, human totipotent or pluripotent cells, human pluripotent stem cell lines, human neural and gonadal progenitor stem cells or other somatic tissues for stem cell research (excluding cells that remain restricted in tissue potential and are not known to possess totipotent or pluripotent potential). Documentation of the provenance of the material(s) is required.

NOTICE: A new NIH policy has taken effect with regard to the HeLa cell line and its derivatives, specifically relating to genome information. An NIH announcement regarding the policy can be found here: http://www.nih.gov/news/health/aug2013/nih-07.htm. While this new policy does not at all restrict use of HeLa cells, it does restrict use of any genomic sequence data from these cells. For complete details, please visit the NCBI HeLa Cell Genome Sequencing Studies website.

Basic ISCRO Review and Approval Procedure

  • The principal investigator* must complete the application form to submit proposed research protocols for review to the committee Chair.
  • The proposed protocols are reviewed to ensure that the science is appropriate and ethical according to accepted stem cell guidelines (NAS and ISSCR) and that all personnel working with stem cells receive ethical training in their use.
  • The approval period is for three years, subject to annual approvals at the end of years one and two.
  • All modifications to the approved protocol must be submitted using the Renewal/Update form and re-approved in writing by the ISCRO prior to implementation.

* The investigator who is primarily responsible for the conduct of the research. Only faculty or staff members may be Principal Investigators. All non-faculty researchers are properly characterized as Co-Investigators.

ISCRO Proposal Review Procedure

Institutional Official (IO)

Wolf von Maltzahn, Ph.D.
Associate Vice President for Research (518) 276-4873; vonmaw@rpi.edu

Direct all inquiries to iscro@rpi.edu

ISCRO Policy Document
ISCRO Application Form
ISCRO Update Renewal Form

Additional Information Regarding Stem Cell Research

Frequently Asked Questions About Stem Cell Research

International Society for Stem Cell Research (ISSCR)

ISSCR: Guidelines

ISSCR: A Closer Look at Stem Cell Treatments

NIH Stem Cell Information

Research!America Stem Cell Research FAQs

New York State Stem Cell Initiative (NYSTEM)

NYSTEM Publications

NIH Supported Stem Cell Training Programs

Wisconsin International Stem Cell Bank

International Stem Cell Registry

NIH Human Embryonic Stem Cell Registry

Induced Pluripotent Cells

Ethical Considerations with Stem Cells

Stem Cell Research Glossary

Organizations and Groups

Page updated: 12/17/10, 6:59 PM
Copyright ©2010 Rensselaer Polytechnic Institute (RPI)  110 Eighth Street, Troy, NY USA 12180  (518) 276-6000  All rights reserved.
Why not change the world?® is a registered trademark of Rensselaer Polytechnic Institute.
Site design and production by the Rensselaer Division of Strategic Communications & External Relations